BioSpace News Archive

HealyWorld has announced it is entering the US market bringing the Healy™ microcurrent medical device to millions of Americans suffering with acute, chronic and arthritis pain.

Decision Diagnostics Corp. www.decisiondiagnostics.co, through its subsidiary Pharma Tech Solutions, Inc., has released an “Open Letter” in support of the FDA’s recent announcement of at-home rapid testing guidelines.

BIOQUAL announces the publication of the successful testing of an mRNA vaccine in non-human primates.

Micro-Tech Endoscopy USA recently announced an expansion of their SureClip portfolio – the Lockado Hemostasis Clip.

Harrow Health, Inc. reported results for the second quarter 2020. Please click here to review Harrow Health’s Letter to Stockholders for the second quarter 2020.

CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, announced corporate updates and financial results for the second quarter and six months ended June 30, 2020.

Longer treatment regimens could be required to see reduction or eradication of more resistant pulmonary strains

HTG Molecular Diagnostics, Inc., a life science company whose mission is to advance precision medicine, announced the signing of a Commercialization and Distribution Agreement with QIAGEN Manchester Limited, a wholly owned subsidiary of QIAGEN N.V.

ENHANCE-IT study of MAT9001 against Vascepa® expected to be fully enrolled in August 2020; topline data anticipated Q1 2021

Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today reported financial results and a business update for the three months ended June 30, 2020.